SEC Comment Letter 0000000000-24-002518 to CASTLE BIOSCIENCES INC (CSTL) (CIK 0001447362) (CSTL)
CASTLE BIOSCIENCES INC (CSTL) (CIK 0001447362)
Date: March 7, 2024 · CIK: 0001447362 · Accession: 0000000000-24-002518
AI Filing Summary & Sentiment
File numbers found in text: 333-277470
Show Raw Text
United States securities and exchange commission logo
March 7, 2024
Derek Maetzold
President and Chief Executive Officer
Castle Biosciences Inc.
505 S. Friendswood Drive, Suite 401
Friendswood, Texas 77546
Re:Castle Biosciences Inc.
Registration Statement on Form S-3
Filed February 28, 2024
File No. 333-277470
Dear Derek Maetzold:
This is to advise you that we have not reviewed and will not review your registration
statement.
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you
that the company and its management are responsible for the accuracy and adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Robert Augustin at 202-551-8483 with any questions.
Sincerely,
Division of Corporation Finance
Office of Industrial Applications and
Services
cc: Thomas Coll